CA2469649C - Derivatives of isoindigo, indigo and indirubin and use in treating cancer - Google Patents
Derivatives of isoindigo, indigo and indirubin and use in treating cancer Download PDFInfo
- Publication number
- CA2469649C CA2469649C CA2469649A CA2469649A CA2469649C CA 2469649 C CA2469649 C CA 2469649C CA 2469649 A CA2469649 A CA 2469649A CA 2469649 A CA2469649 A CA 2469649A CA 2469649 C CA2469649 C CA 2469649C
- Authority
- CA
- Canada
- Prior art keywords
- cancer
- compound
- natura
- agents
- meisoindigo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/021,589 US6566341B1 (en) | 2001-12-13 | 2001-12-13 | Derivative of isoindigo, indigo and indirubin for the treatment of cancer |
| US10/021,589 | 2001-12-13 | ||
| US40726702P | 2002-09-03 | 2002-09-03 | |
| US60/407,267 | 2002-09-03 | ||
| PCT/US2002/039866 WO2003051900A1 (en) | 2001-12-13 | 2002-12-13 | Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2469649A1 CA2469649A1 (en) | 2003-06-26 |
| CA2469649C true CA2469649C (en) | 2011-05-03 |
Family
ID=26694875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2469649A Expired - Lifetime CA2469649C (en) | 2001-12-13 | 2002-12-13 | Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
Country Status (8)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8563525B2 (en) | 2004-01-12 | 2013-10-22 | Natrogen Therapeutics International, Inc. | Methods of treating an inflammatory-related disease |
| US20100098702A1 (en) * | 2008-09-16 | 2010-04-22 | Longgui Wang | Method of treating androgen independent prostate cancer |
| US7582670B2 (en) | 2001-12-13 | 2009-09-01 | Natrogen Therapeutics, Inc. | Methods of treating an inflammatory-related disease |
| US20050154046A1 (en) | 2004-01-12 | 2005-07-14 | Longgui Wang | Methods of treating an inflammatory-related disease |
| US8748475B2 (en) | 2004-01-12 | 2014-06-10 | Natrogen Therapeutics International, Inc. | Methods and compositions for treating lupus |
| CN101074229B (zh) * | 2007-06-08 | 2010-09-01 | 无锡杰西医药科技有限公司 | 7-氮杂靛玉红和7-氮杂异靛蓝衍生物制备及其药学用途 |
| CN101426268B (zh) * | 2007-11-02 | 2010-08-25 | 大唐移动通信设备有限公司 | 导频资源分配方法、系统和设备 |
| US8563595B2 (en) * | 2008-11-14 | 2013-10-22 | Board Of Regents, The University Of Texas System | Treatment of cancer with complex organic-inorganic pigment compositions |
| AU2013234955A1 (en) * | 2012-03-23 | 2014-11-13 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| CN104602675B (zh) | 2012-06-21 | 2019-06-28 | 法斯瑞斯公司 | 靛玉红的奈米粒子、其衍生物以及制造和使用所述奈米粒子的方法 |
| CN103333161B (zh) * | 2013-05-28 | 2015-09-30 | 滁州市洛达生物科技有限公司 | 1’-氧代靛玉红的制备和用途 |
| AU2018272591B2 (en) | 2017-05-26 | 2020-05-28 | Taiho Pharmaceutical Co., Ltd. | Novel biphenyl compound or salt thereof |
| EP3632443B1 (en) * | 2017-05-26 | 2023-06-07 | Taiho Pharmaceutical Co., Ltd. | Anti-tumor effect potentiator using a biphenyl compound |
| MX2021006464A (es) * | 2018-12-07 | 2021-09-28 | Natrogen Therapeutics Int Inc | Forma polimorfica de meisoindigo y formulacion modificada de meisoindigo. |
| US11345818B1 (en) | 2020-12-29 | 2022-05-31 | Industrial Technology Research Institute | Dye for fiber and dyeing method |
| US20240285660A1 (en) * | 2021-04-27 | 2024-08-29 | Curapep Llc | Composition for wound relief and inhibiting a phd protein and methods of treatment |
| CN114920728B (zh) * | 2022-05-27 | 2023-10-20 | 中南大学 | 一种甲异靛衍生物及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS617254A (ja) * | 1984-06-20 | 1986-01-13 | Isukura Sangyo Kk | ビスインドリノンおよびそれを主成分とする制癌剤 |
| US5696092A (en) | 1995-03-07 | 1997-12-09 | George Washington University | Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers |
| CA2333661A1 (en) * | 1998-05-29 | 1999-12-09 | Cnrs (Centre National De Recherche Scientifique) France Innovation Scien Tifique Et Transfernt | Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
| SK14272001A3 (sk) * | 1999-04-12 | 2002-05-09 | Gerhard Eisenbrand | Indigoidné bisindolové deriváty |
| ATE427746T1 (de) * | 1999-04-12 | 2009-04-15 | Heinz Herbert Fiebig | 5-methylindirubin zur verwendung in der behandlung von menschlichen festen tumoren |
-
2002
- 2002-12-13 AU AU2002357191A patent/AU2002357191A1/en not_active Abandoned
- 2002-12-13 WO PCT/US2002/039866 patent/WO2003051900A1/en active Search and Examination
- 2002-12-13 EP EP02805123A patent/EP1458734B1/en not_active Expired - Lifetime
- 2002-12-13 JP JP2003552781A patent/JP2005516938A/ja active Pending
- 2002-12-13 AT AT02805123T patent/ATE484514T1/de not_active IP Right Cessation
- 2002-12-13 CA CA2469649A patent/CA2469649C/en not_active Expired - Lifetime
- 2002-12-13 DE DE60237993T patent/DE60237993D1/de not_active Expired - Lifetime
-
2004
- 2004-06-10 US US10/864,458 patent/US6933315B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1458734A4 (en) | 2007-12-19 |
| CA2469649A1 (en) | 2003-06-26 |
| ATE484514T1 (de) | 2010-10-15 |
| WO2003051900A1 (en) | 2003-06-26 |
| US6933315B2 (en) | 2005-08-23 |
| EP1458734B1 (en) | 2010-10-13 |
| EP1458734A1 (en) | 2004-09-22 |
| US20040225002A1 (en) | 2004-11-11 |
| DE60237993D1 (de) | 2010-11-25 |
| AU2002357191A1 (en) | 2003-06-30 |
| JP2005516938A (ja) | 2005-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2469649C (en) | Derivatives of isoindigo, indigo and indirubin and use in treating cancer | |
| Shen et al. | Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway | |
| Nafie et al. | Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer | |
| Yang et al. | Structure-activity relationship studies of phenothiazine derivatives as a new class of ferroptosis inhibitors together with the therapeutic effect in an ischemic stroke model | |
| Gul et al. | New copper complexes inducing bimodal death through apoptosis and autophagy in A549 cancer cells | |
| EP2673250B1 (en) | Stilbene analogs and methods of treating cancer | |
| Bauer et al. | Synthesis, characterization and biological activity of new cyclometallated platinum (iv) iodido complexes | |
| Ling et al. | Development of novel amino-quinoline-5, 8-dione derivatives as NAD (P) H: quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities | |
| Hua et al. | Multifunctional platinum (IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2, 3-dioxygenase | |
| Xu et al. | 17β-Hydroxywithanolides as sensitizers of renal carcinoma cells to tumor necrosis factor-α related apoptosis inducing ligand (TRAIL) mediated apoptosis: Structure–activity relationships | |
| Biegański et al. | Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro | |
| Pu et al. | Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer | |
| Khodair et al. | Discovery of New S‐Glycosides and N‐Glycosides of Pyridine‐biphenyl System with Antiviral Activity and Induction of Apoptosis in MCF 7 Cells | |
| Srour et al. | Synthesis and cytotoxic properties of new substituted glycosides-indole conjugates as apoptosis inducers in cancer cells | |
| ES2354509T3 (es) | Derivados de isoíndigo, índigo e indirubina y su uso en el tratamiento del cáncer. | |
| Zhang et al. | Cyclophilin D: guardian or executioner for tumor cells? | |
| US10730840B2 (en) | Substituted tetrahydroisoquinoline ethylbenzamide anti-cancer agents | |
| JP2021514955A (ja) | プロテアソーム関連ユビキチン受容体ｒｐｎ１３機能を阻止する低分子およびその使用法 | |
| JP7018191B2 (ja) | 細胞内物質移送システムおよびその利用 | |
| Li et al. | Synthesis and biological evaluation of geldanamycin–ferulic acid conjugate as a potent Hsp90 inhibitor | |
| Huang et al. | A cytotoxic nitrido-osmium (VI) complex induces caspase-mediated apoptosis in HepG2 cancer cells | |
| Ma et al. | ML162 derivatives incorporating a naphthoquinone unit as ferroptosis/apoptosis inducers: Design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation | |
| Qin et al. | Discovery of 5-((4-(pyridin-3-yl) pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel anti-cancer agents targeting Nur77 | |
| KR20150041786A (ko) | 암치료 및 면역억제를 위한 조합요법 | |
| Yuan et al. | Pioneering 4, 11-Dioxo-4, 11-dihydro-1 H-anthra [2, 3-d] imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20221213 |